{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-201662","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.870639+00:00","generated_at":"2026-05-15T00:21:01.235682+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AVITA Medical appoints Cary Vance as permanent CEO, Jan Stern Reed as Board Chair","bullets":["Cary Vance named President and CEO effective April 30, 2026; served as Interim CEO since October 2025.","Jan Stern Reed appointed Chair of the Board; had been Lead Independent Director since October 2025.","Vance receives $702k base salary, 80% bonus target, and $3.354M in equity awards subject to stockholder approval.","Employment agreement: 3-year initial term; severance of 18 months base salary plus COBRA if terminated without cause."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201662","json":"https://secwatch.observer/filing/0001193125-26-201662.json","markdown":"https://secwatch.observer/filing/0001193125-26-201662.md","text":"https://secwatch.observer/filing/0001193125-26-201662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/rcel-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:21:01.235682+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"561ee0a0dc","claim":"Jan Stern Reed was appointed as Chair of the Board at AVITA Medical, Inc..","evidence_excerpt":"the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Board"}],"fact_type":"executive_change"},{"claim_id":"a7fc03bf5e","claim":"Cary Vance was appointed as President and Chief Executive Officer at AVITA Medical, Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of AVITA Medical, Inc (the \"Company\") appointed Cary Vance as President and Chief Executive Officer (\"CEO\"), effective April 30, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}